Phase III randomized, double-blind, active control, multi-center trial of AD-207 for patients with primary hypercholesterolemia and essential hypertension
Latest Information Update: 23 Dec 2020
At a glance
- Drugs AD 207 (Primary)
- Indications Essential hypertension; Hypercholesterolaemia
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2020 New trial record